Literature DB >> 28167456

Antidepressant and anxiolytic-like activity of sodium selenite after acute treatment in mice.

Ewa Kędzierska1, Jarosław Dudka2, Ewa Poleszak3, Jolanta H Kotlińska4.   

Abstract

BACKGROUND: Selenium (Se) is an essential trace element for humans and animals, that is needed for a broad variety of physiological functions including thyroid hormone metabolism, protection against oxidative stress, and immunity associated functions. Human nutritional Se deficiencies are associated with neuropsychiatric diseases, like Alzheimer's disease, Parkinson's disease, obsessive - compulsive disorder, stroke, epilepsy as well as depressive behaviours. In this study we examined antidepressant- and anxiolytic-like activity of Se in the inorganic form of sodium selenite and investigated whether Se influence on the locomotor activity in mice.
METHODS: The antidepressant-like and anxiolytic-like activity of Se was assessed using forced swim test (FST) and elevated plus-maze test (EPM), respectively. Spontaneous locomotor activity was measured using photoresistor actimeters.
RESULTS: Sodium selenite administered at the doses of 0.5, 1, and 2mg/kg, ip reduced immobility time in the FST exerting antidepressant-like activity. In the EPM test, sodium selenite at the same doses, produced anxiolytic-like effect; the doses active in both tests did not affect locomotor activity, indicating that these effects of Se are specific.
CONCLUSIONS: These potential antidepressant- and anxiolytic-like effects of Se require more detailed experimental study using animal models to approach a clear conclusion regarding the potential mechanism of the observed effect.
Copyright © 2016. Published by Elsevier Urban & Partner Sp. z o.o.

Entities:  

Keywords:  Elevated plus-maze test; Forced swim test; Locomotor activity; Mice; Sodium selenite

Mesh:

Substances:

Year:  2016        PMID: 28167456     DOI: 10.1016/j.pharep.2016.11.005

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Combination of levetiracetam with sodium selenite prevents pentylenetetrazole-induced kindling and behavioral comorbidities in rats.

Authors:  Zohabia Rehman; Talha Farooq; Sana Javaid; Waseem Ashraf; Muhammad Fawad Rasool; Noreen Samad; Maryam Tariq; Syed Muhammad Muneeb Anjum; Farzane Sivandzade; Faisal Alotaibi; Faleh Alqahtani; Imran Imran
Journal:  Saudi Pharm J       Date:  2022-03-10       Impact factor: 4.562

2.  Inhibitory Effects of Selenium on Arsenic-Induced Anxiety-/Depression-Like Behavior and Memory Impairment.

Authors:  Noreen Samad; Tazeen Rao; Muhammad Habib Ur Rehman; Sheraz Ahmed Bhatti; Imran Imran
Journal:  Biol Trace Elem Res       Date:  2021-03-20       Impact factor: 3.738

3.  Effects of Selen on the Antidepressant-like Activity of Agents Affecting the Adenosinergic Neurotransmission.

Authors:  Aleksandra Szopa; Mariola Herbet; Ewa Poleszak; Karolina Bogatko; Marta Ostrowska-Leśko; Katarzyna Świąder; Jarosław Szponar; Anna Serefko
Journal:  Metabolites       Date:  2022-06-23

4.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

5.  GC-MS Phytochemical Profiling, Pharmacological Properties, and In Silico Studies of Chukrasia velutina Leaves: A Novel Source for Bioactive Agents.

Authors:  Israt Jahan; Marzia Rahman Tona; Sanjida Sharmin; Mohammed Aktar Sayeed; Fatamatuz Zuhura Tania; Arkajyoti Paul; Md Nazim Uddin Chy; Ahmed Rakib; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Molecules       Date:  2020-08-02       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.